9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Proteome Characterization of BALF Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Unveiling Undercover Molecular Pathways

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the longtime challenge of identifying specific, easily detectable and reliable biomarkers of IPF, BALF proteomics is providing interesting new insights into its pathogenesis. To the best of our knowledge, the present study is the first shotgun proteomic investigation of EVs isolated from BALF of IPF patients. Our main aim was to characterize the proteome of the vesicular component of BALF and to explore its individual impact on the pathogenesis of IPF. To this purpose, ultracentrifugation was chosen as the EVs isolation technique, and their purification was assessed by TEM, 2DE and LC-MS/MS. Our 2DE data and scatter plots showed considerable differences between the proteome of EVs and that of whole BALF and of its fluid component. Analysis of protein content and protein functions evidenced that EV proteins are predominantly involved in cytoskeleton remodeling, adenosine signaling, adrenergic signaling, C-peptide signaling and lipid metabolism. Our findings may suggest a wider system involvement in the disease pathogenesis and support the importance of pre-fractioning of complex samples, such as BALF, in order to let low-abundant proteins-mediated pathways emerge.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis

          The use of extracellular vesicles, specifically exosomes, as carriers of biomarkers in extracellular spaces has been well demonstrated. Despite their promising potential, the use of exosomes in the clinical setting is restricted due to the lack of standardization in exosome isolation and analysis methods. The purpose of this review is to not only introduce the different types of extracellular vesicles but also to summarize their differences and similarities, and discuss different methods of exosome isolation and analysis currently used. A thorough understanding of the isolation and analysis methods currently being used could lead to some standardization in the field of exosomal research, allowing the use of exosomes in the clinical setting to become a reality.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Isolation and characterization of exosomes from cell culture supernatants and biological fluids.

            Exosomes are small membrane vesicles found in cell culture supernatants and in different biological fluids. Exosomes form in a particular population of endosomes, called multivesicular bodies (MVBs), by inward budding into the lumen of the compartment. Upon fusion of MVBs with the plasma membrane, these internal vesicles are secreted. Exosomes possess a defined set of membrane and cytosolic proteins. The physiological function of exosomes is still a matter of debate, but increasing results in various experimental systems suggest their involvement in multiple biological processes. Because both cell-culture supernatants and biological fluids contain different types of lipid membranes, it is critical to perform high-quality exosome purification. This unit describes different approaches for exosome purification from various sources, and discusses methods to evaluate the purity and homogeneity of the purified exosome preparations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

              In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, and provided standardized terminology and diagnostic criteria. In addition, the historical "gold standard" of histologic diagnosis was replaced by a multidisciplinary approach. Since 2002 many publications have provided new information about IIPs. The objective of this statement is to update the 2002 ATS/ERS classification of IIPs. An international multidisciplinary panel was formed and developed key questions that were addressed through a review of the literature published between 2000 and 2011. Substantial progress has been made in IIPs since the previous classification. Nonspecific interstitial pneumonia is now better defined. Respiratory bronchiolitis-interstitial lung disease is now commonly diagnosed without surgical biopsy. The clinical course of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia is recognized to be heterogeneous. Acute exacerbation of IIPs is now well defined. A substantial percentage of patients with IIP are difficult to classify, often due to mixed patterns of lung injury. A classification based on observed disease behavior is proposed for patients who are difficult to classify or for entities with heterogeneity in clinical course. A group of rare entities, including pleuroparenchymal fibroelastosis and rare histologic patterns, is introduced. The rapidly evolving field of molecular markers is reviewed with the intent of promoting additional investigations that may help in determining diagnosis, and potentially prognosis and treatment. This update is a supplement to the previous 2002 IIP classification document. It outlines advances in the past decade and potential areas for future investigation.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                27 May 2021
                June 2021
                : 22
                : 11
                : 5696
                Affiliations
                [1 ]Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy; enxhi.shaba@ 123456unisi.it
                [2 ]Functional Proteomics Lab, Department of Life Sciences, University of Siena, 53100 Siena, Italy; lorenz.vantaggiato@ 123456student.unisi.it (L.V.); bianchi12@ 123456unisi.it (L.B.); luca.bini@ 123456unisi.it (L.B.)
                [3 ]Department of Pulmonology, Medizinische Hochschule Hannover at Fraunhofer-Institut für Toxikologie und Experimentelle Medizin, 30625 Hannover, Germany; carleo.alfonso@ 123456mh-hannover.de (A.C.); prasse.antje@ 123456mh-hannover.de (A.P.)
                [4 ]Department of Life Sciences, University of Siena, 53100 Siena, Italy; eugenio.paccagnini@ 123456unisi.it (E.P.); mariangela.gentile@ 123456unisi.it (M.G.); pietro.lupetti@ 123456unisi.it (P.L.)
                [5 ]Respiratory Diseases and Lung Transplantation, Department Internal and Specialist Medicine, University of Siena, Viale Bracci 16, 53100 Siena, Italy
                Author notes
                [* ]Correspondence: landi35@ 123456unisi.it (C.L.); bargagli2@ 123456gmail.com (E.B.)
                [†]

                The authors considered that these authors should be regarded as joined First Authors.

                [‡]

                Prasse A. and Bini L. have been acting as senior investigators and should be considered equally Last Authors.

                Author information
                https://orcid.org/0000-0002-9561-2426
                https://orcid.org/0000-0003-0410-8038
                https://orcid.org/0000-0002-2795-9583
                https://orcid.org/0000-0002-9784-2057
                https://orcid.org/0000-0002-4928-4652
                https://orcid.org/0000-0001-9219-1227
                https://orcid.org/0000-0003-4316-9861
                https://orcid.org/0000-0002-8351-3703
                https://orcid.org/0000-0001-8951-2106
                Article
                ijms-22-05696
                10.3390/ijms22115696
                8199247
                34071777
                7265d539-de5f-466a-a659-2d0a46b87c9f
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 23 April 2021
                : 24 May 2021
                Categories
                Article

                Molecular biology
                shotgun proteomics,evs,ipf,balf
                Molecular biology
                shotgun proteomics, evs, ipf, balf

                Comments

                Comment on this article